Literature DB >> 35413274

Klebsiella pneumoniae induces host metabolic stress that promotes tolerance to pulmonary infection.

Tania Wong Fok Lung1, Daniel Charytonowicz2, Kristin G Beaumont2, Shivang S Shah3, Shwetha H Sridhar2, Claire L Gorrie4, Andre Mu4, Casey E Hofstaedter5, David Varisco5, Thomas H McConville6, Marija Drikic7, Brandon Fowler8, Andreacarola Urso3, Wei Shi3, Dario Fucich3, Medini K Annavajhala9, Ibrahim N Khan3, Irina Oussenko2, Nancy Francoeur2, Melissa L Smith2, Brent R Stockwell10, Ian A Lewis7, Abderrahman Hachani4, Swikrity Upadhyay Baskota11, Anne-Catrin Uhlemann9, Danielle Ahn3, Robert K Ernst5, Benjamin P Howden12, Robert Sebra13, Alice Prince14.   

Abstract

K. pneumoniae sequence type 258 (Kp ST258) is a major cause of healthcare-associated pneumonia. However, it remains unclear how it causes protracted courses of infection in spite of its expression of immunostimulatory lipopolysaccharide, which should activate a brisk inflammatory response and bacterial clearance. We predicted that the metabolic stress induced by the bacteria in the host cells shapes an immune response that tolerates infection. We combined in situ metabolic imaging and transcriptional analyses to demonstrate that Kp ST258 activates host glutaminolysis and fatty acid oxidation. This response creates an oxidant-rich microenvironment conducive to the accumulation of anti-inflammatory myeloid cells. In this setting, metabolically active Kp ST258 elicits a disease-tolerant immune response. The bacteria, in turn, adapt to airway oxidants by upregulating the type VI secretion system, which is highly conserved across ST258 strains worldwide. Thus, much of the global success of Kp ST258 in hospital settings can be explained by the metabolic activity provoked in the host that promotes disease tolerance.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Klebsiella pneumoniae; M2 macrophages; MDSCs; bacterial adaptation; disease tolerance; immunometabolism; immunosuppression; itaconate; pulmonary infection; type 6 secretion system

Mesh:

Year:  2022        PMID: 35413274      PMCID: PMC9081115          DOI: 10.1016/j.cmet.2022.03.009

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   31.373


  81 in total

1.  Metabolomic analysis and visualization engine for LC-MS data.

Authors:  Eugene Melamud; Livia Vastag; Joshua D Rabinowitz
Journal:  Anal Chem       Date:  2010-11-04       Impact factor: 6.986

2.  LC-MS data processing with MAVEN: a metabolomic analysis and visualization engine.

Authors:  Michelle F Clasquin; Eugene Melamud; Joshua D Rabinowitz
Journal:  Curr Protoc Bioinformatics       Date:  2012-03

3.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

4.  Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies.

Authors:  Fokhrul Hossain; Amir A Al-Khami; Dorota Wyczechowska; Claudia Hernandez; Liqin Zheng; Krzystoff Reiss; Luis Del Valle; Jimena Trillo-Tinoco; Tomasz Maj; Weiping Zou; Paulo C Rodriguez; Augusto C Ochoa
Journal:  Cancer Immunol Res       Date:  2015-05-29       Impact factor: 11.151

5.  Emergence of Polymyxin Resistance in Clinical Klebsiella pneumoniae Through Diverse Genetic Adaptations: A Genomic, Retrospective Cohort Study.

Authors:  Nenad Macesic; Brian Nelson; Thomas H Mcconville; Marla J Giddins; Daniel A Green; Stephania Stump; Angela Gomez-Simmonds; Medini K Annavajhala; Anne-Catrin Uhlemann
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

Review 6.  Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

Authors:  Douglas Marvel; Dmitry I Gabrilovich
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

7.  Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis.

Authors:  Ajit S Divakaruni; Wei Yuan Hsieh; Lucía Minarrieta; Tin N Duong; Kristen K O Kim; Brandon R Desousa; Alexander Y Andreyev; Caitlyn E Bowman; Kacey Caradonna; Brian P Dranka; David A Ferrick; Marc Liesa; Linsey Stiles; George W Rogers; Daniel Braas; Theodore P Ciaraldi; Michael J Wolfgang; Tim Sparwasser; Luciana Berod; Steven J Bensinger; Anne N Murphy
Journal:  Cell Metab       Date:  2018-06-28       Impact factor: 27.287

8.  Siderophore-Mediated Iron Acquisition Enhances Resistance to Oxidative and Aromatic Compound Stress in Cupriavidus necator JMP134.

Authors:  Changfu Li; Lingfang Zhu; Damin Pan; Shuyu Li; He Xiao; Zhenxing Zhang; Xihui Shen; Yao Wang; Mingxiu Long
Journal:  Appl Environ Microbiol       Date:  2018-12-13       Impact factor: 4.792

9.  SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.

Authors:  Sabina Sangaletti; Giovanna Talarico; Claudia Chiodoni; Barbara Cappetti; Laura Botti; Paola Portararo; Alessandro Gulino; Francesca Maria Consonni; Antonio Sica; Giovanni Randon; Massimo Di Nicola; Claudio Tripodo; Mario P Colombo
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

10.  Klebsiella pneumoniae Type VI Secretion System Contributes to Bacterial Competition, Cell Invasion, Type-1 Fimbriae Expression, and In Vivo Colonization.

Authors:  Pei-Fang Hsieh; Yi-Rou Lu; Tzu-Lung Lin; Li-Yin Lai; Jin-Town Wang
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

View more
  2 in total

Review 1.  Anti-Inflammatory Metabolites in the Pathogenesis of Bacterial Infection.

Authors:  Andreacarola Urso; Alice Prince
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

2.  Role of Klebsiella pneumoniae Type VI secretion system (T6SS) in long-term gastrointestinal colonization.

Authors:  Thomas Merciecca; Stéphanie Bornes; Laurence Nakusi; Sébastien Theil; Olaya Rendueles; Christiane Forestier; Sylvie Miquel
Journal:  Sci Rep       Date:  2022-10-10       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.